1. Home
  2. APLT vs XMTR Comparison

APLT vs XMTR Comparison

Compare APLT & XMTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLT
  • XMTR
  • Stock Information
  • Founded
  • APLT 2016
  • XMTR 2013
  • Country
  • APLT United States
  • XMTR United States
  • Employees
  • APLT N/A
  • XMTR N/A
  • Industry
  • APLT Biotechnology: Pharmaceutical Preparations
  • XMTR Industrial Machinery/Components
  • Sector
  • APLT Health Care
  • XMTR Technology
  • Exchange
  • APLT Nasdaq
  • XMTR Nasdaq
  • Market Cap
  • APLT 971.6M
  • XMTR 1.0B
  • IPO Year
  • APLT 2019
  • XMTR 2021
  • Fundamental
  • Price
  • APLT $9.40
  • XMTR $22.73
  • Analyst Decision
  • APLT Strong Buy
  • XMTR Buy
  • Analyst Count
  • APLT 5
  • XMTR 7
  • Target Price
  • APLT $12.50
  • XMTR $22.86
  • AVG Volume (30 Days)
  • APLT 1.6M
  • XMTR 438.7K
  • Earning Date
  • APLT 11-15-2024
  • XMTR 11-05-2024
  • Dividend Yield
  • APLT N/A
  • XMTR N/A
  • EPS Growth
  • APLT N/A
  • XMTR N/A
  • EPS
  • APLT N/A
  • XMTR N/A
  • Revenue
  • APLT N/A
  • XMTR $502,357,000.00
  • Revenue This Year
  • APLT N/A
  • XMTR $18.62
  • Revenue Next Year
  • APLT $3,358.27
  • XMTR $18.15
  • P/E Ratio
  • APLT N/A
  • XMTR N/A
  • Revenue Growth
  • APLT N/A
  • XMTR 20.19
  • 52 Week Low
  • APLT $1.79
  • XMTR $11.08
  • 52 Week High
  • APLT $9.39
  • XMTR $38.74
  • Technical
  • Relative Strength Index (RSI)
  • APLT 56.53
  • XMTR 68.48
  • Support Level
  • APLT $8.38
  • XMTR $19.16
  • Resistance Level
  • APLT $9.28
  • XMTR $23.30
  • Average True Range (ATR)
  • APLT 0.51
  • XMTR 1.16
  • MACD
  • APLT -0.07
  • XMTR 0.21
  • Stochastic Oscillator
  • APLT 49.48
  • XMTR 79.52

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

About XMTR Xometry Inc.

Xometry Inc is engaged in providing AI-enabled manufacturing equipment. Its buyers include engineers, product designers, procurement and supply chain personnel, inventors, and business owners. The manufacturing processes offered by the company include CNC Machining, Injection Molding, Urethane Casting, 3D Printing, and Die Casting. The company is organized into two segments referred to as the U.S. and the International. The majority of the revenue is earned from the U.S. segment.

Share on Social Networks: